Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if nivolumab and ipilimumab are effective treatment
for people with pituitary tumors have gotten worse after surgery and radiation.